Skip to main content
. 2020 Mar 30;21(7):2378. doi: 10.3390/ijms21072378
APC Antigen presenting cell
CBI checkpoints blockade immunotherapy
CDR3 complementarity-determining region 3
HTS high-throughput sequencing
MHC major histocompatibility complex
NSCLC non–small-cell lung cancer
PCR polymerase chain reaction
RACE rapid amplification of cDNA ends
SSC squamous cell carcinoma
TCR T cell receptor
UMIs unique molecular identifiers
VDJ variable (V), diversity (D), and joining (J) gene segments